Log In
Print this Print this

ImatiRel, imatinib mesylate

  Manage Alerts
Collapse Summary General Information
Company Reliance Life Sciences
DescriptionOral synthetic tyrosine kinase inhibitor
Molecular Target Platelet derived growth factor receptor (PDGFR) ; Protein tyrosine kinase (PTK)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today